Close

Ascentage Pharma Announces Another Milestone Payment from Its Licensee UNITY Biotechnology, Rapidly Advancing the Clinical Development of Senolytic Drug Candidate UBX1325

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. SPY
5. INFY
6. SNV
7. TSLA
8. SMCI
9. SLB
10. PPG


Go back to Ascentage Pharma Announces Another Milestone Payment from Its Licensee UNITY Biotechnology, Rapidly Advancing the Clinical Development of Senolytic Drug Candidate UBX1325
(NASDAQ: UBX) Delayed: 1.50 -0.01 (0.66%)
Previous Close $1.51    52 Week High $ 
Open $1.51    52 Week Low $ 
Day High $1.52    P/E N/A 
Day Low $1.50    EPS $ 
Volume 45,504